title: Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides.
abstract: CRIPTO is an epidermal growth factor-related gene expressed in a majority of human colorectal tumors. To assess the role of CRIPTO in the growth control of human colon cancer, we have treated human colon carcinoma GEO and CBS cells, that possess high levels of CRIPTO, and WIDR colon cancer cells, that are negative for CRIPTO expression, with two antisense phosphorothioate oligodeoxynucleotides complementary to the 5' end of the human CRIPTO mRNA. Both antisense oligodeoxynucleotides significantly reduced endogenous CRIPTO protein levels and inhibited GEO and CBS cell growth in monolayer and in semisolid medium, whereas they did not affect WIDR cell growth. In addition, GEO, CBS and WIDR cells were infected with a recombinant retroviral vector containing the hygromycin-resistance gene and a 900 bp EcoRI-EcoRI coding fragment of the human CRIPTO cDNA oriented in the 3' to 5' direction. GEO and CBS CRIPTO antisense infectants exhibited a 60 to 70% reduction in CRIPTO protein expression, in monolayer growth and in soft agar cloning efficiency as compared to parental noninfected cells. In contrast, infection of WIDR cells with the CRIPTO antisense retrovirus did not alter their growth. Finally, GEO CRIPTO antisense infectants formed tumors in nude mice that were significantly smaller and had a larger latency period as compared to noninfected GEO cells.
authors.affiliation: Cattedra di Oncologia Medica, Facoltà di Medicina e Chirurgia, Università degli Studi di Napoli Federico II, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Ciardiello
authors.forename: G
authors.initials: G
authors.lastname: Tortora
authors.forename: C
authors.initials: C
authors.lastname: Bianco
authors.forename: M P
authors.initials: MP
authors.lastname: Selvam
authors.forename: F
authors.initials: F
authors.lastname: Basolo
authors.forename: G
authors.initials: G
authors.lastname: Fontanini
authors.forename: F
authors.initials: F
authors.lastname: Pacifico
authors.forename: N
authors.initials: N
authors.lastname: Normanno
authors.forename: R
authors.initials: R
authors.lastname: Brandt
authors.forename: M G
authors.initials: MG
authors.lastname: Persico
mesh_terms: D000818:Animals; D001483:Base Sequence; D002478:Cells, Cultured; D003110:Colonic Neoplasms / Q000235:genetics* / Q000517:prevention & control*; D004815:Epidermal Growth Factor; D005260:Female; D058851:GPI-Linked Proteins; D015870:Gene Expression; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins; D008562:Membrane Glycoproteins; D051379:Mice; D008807:Mice, Inbred BALB C; D008969:Molecular Sequence Data; D009363:Neoplasm Proteins / Q000235:genetics*; D016376:Oligonucleotides, Antisense / Q000494:pharmacology*; D016372:RNA, Antisense / Q000494:pharmacology*; D016211:Transforming Growth Factor alpha / Q000235:genetics / Q000502:physiology
chemical_list: D058851:GPI-Linked Proteins; D036341:Intercellular Signaling Peptides and Proteins; D008562:Membrane Glycoproteins; D009363:Neoplasm Proteins; D016376:Oligonucleotides, Antisense; D016372:RNA, Antisense; C070636:TDGF1 protein, human; C489450:Tdgf1 protein, mouse; D016211:Transforming Growth Factor alpha; D004815:Epidermal Growth Factor